T-1330 is a pharmaceutical intermediate featuring a triazolone core linked to a piperazine-substituted phenyl group and a hydroxyphenyl group. It is primarily used in the research and manufacturing of active pharmaceutical ingredients.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 106461-41-0
2,4-Dihydro-4-[4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one
Pharmaceutical intermediate
2-Bromo-4-fluoro-5-methylaniline
Pharmaceutical intermediate for synthesis
Ethynyltrimethylsilane
Pharmaceutical intermediate building block
Methyl 2,4-difluorobenzoate
Pharmaceutical intermediate
N-Sulphamyl-3-chloropropionamidine hydrochloride
pharmaceutical intermediate
2-butan-2-yl-4-[4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl]-1,2,4-triazol-3-one
FFAQILVGBAELHN-UHFFFAOYSA-N
CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)O